Polymorphisms in Stromal Genes and Susceptibility to Serous Epithelial Ovarian Cancer: A Report from the Ovarian Cancer Association Consortium

• Ernest K. Amankwah,

  Affiliation Department of Population Health Research, Alberta Health Services-Cancer Care, Calgary, Alberta, Canada

  ⨯
• Qinggang Wang,

  Affiliation Department of Population Health Research, Alberta Health Services-Cancer Care, Calgary, Alberta, Canada

  ⨯
• Joellen M. Schildkraut,

  Affiliation Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Ya-Yu Tsai,

  Affiliation Division of Cancer Prevention and Control, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America

  ⨯
• Susan J. Ramus,

  Affiliation Department of Gynaecological Oncology, UCL EGA Institute for Women's Health, University College London, London, United Kingdom

  ⨯
• Brooke L. Fridley,

  Affiliation Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Jonathan Beesley,

  Affiliation The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Australia

  ⨯
• Sharon E. Johnatty,

  Affiliation The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Australia

  ⨯
• Penelope M. Webb,

  Affiliation The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Australia

  ⨯
• Georgia Chenevix-Trench,

  Affiliation The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Australia

  ⨯
• Australian Ovarian Cancer Study Group,

  Affiliations The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Australia, Peter MacCallum Cancer Centre, Melbourne, Australia

  ⨯
• Laura C. Dale,

  Affiliation Department of Population Health Research, Alberta Health Services-Cancer Care, Calgary, Alberta, Canada

  ⨯
• Diether Lambrechts,

  Affiliation Vesalius Research Center, VIB and KU Leuven, Leuven, Belgium

  ⨯
• Frederic Amant,

  Affiliation Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium

  ⨯
• Evelyn Despierre,

  Affiliation Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium

  ⨯
• Ignace Vergote,

  Affiliation Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium

  ⨯
• Simon A. Gayther,

  Affiliation Department of Gynaecological Oncology, UCL EGA Institute for Women's Health, University College London, London, United Kingdom

  ⨯
• Aleksandra Gentry-Maharaj,

  Affiliation Department of Gynaecological Oncology, UCL EGA Institute for Women's Health, University College London, London, United Kingdom

  ⨯
• Usha Menon,

  Affiliation Department of Gynaecological Oncology, UCL EGA Institute for Women's Health, University College London, London, United Kingdom

  ⨯
• Jenny Chang-Claude,

  Affiliation Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany

  ⨯
• Shan Wang-Gohrke,

  Affiliation Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany

  ⨯
• Hoda Anton-Culver,

  Affiliation Department of Epidemiology, School of Medicine, University of California Irvine, Irvine, California, United States of America

  ⨯
• Argyrios Ziogas,

  Affiliation Department of Epidemiology, School of Medicine, University of California Irvine, Irvine, California, United States of America

  ⨯
• Thilo Dörk,

  Affiliation Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany

  ⨯
• Matthias Dürst,

  Affiliation Department of Gynaecology, Jena University Hospital, Jena, Germany

  ⨯
• Natalia Antonenkova,

  Affiliation Byelorussian Institute for Oncology and Medical Radiology Aleksandrov N.N., Minsk, Belarus

  ⨯
• Natalia Bogdanova,

  Affiliations Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany, Byelorussian Institute for Oncology and Medical Radiology Aleksandrov N.N., Minsk, Belarus

  ⨯
• Robert Brown,

  Affiliation Epigenetics Unit, Department of Surgery and Cancer, Imperial College London, London, United Kingdom

  ⨯
• James M. Flanagan,

  Affiliation Epigenetics Unit, Department of Surgery and Cancer, Imperial College London, London, United Kingdom

  ⨯
• Stanley B. Kaye,

  Affiliation Section of Medicine, Institute Cancer Research, Sutton, United Kingdom

  ⨯
• James Paul,

  Affiliation The Beatson West of Scotland Cancer Centre, Glasgow University, Glasgow, United Kingdom

  ⨯
• Ralf Bützow,

  Affiliation Department of Pathology, University of Helsinki, Haartman Insitute, Helsinki, Finland

  ⨯
• Heli Nevanlinna,

  Affiliation Department of Obstetrics and Gynecology, Helsinki University, Central Hospital, Helsinki, Finland

  ⨯
• Ian Campbell,

  Affiliations Peter MacCallum Cancer Centre, Melbourne, Australia, Department of Pathology, University of Melbourne, Parkville, Australia

  ⨯
• Diana M. Eccles,

  Affiliation Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, United Kingdom

  ⨯
• Beth Y. Karlan,

  Affiliation Women's Cancer Research Institute at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Jenny Gross,

  Affiliation Women's Cancer Research Institute at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Christine Walsh,

  Affiliation Women's Cancer Research Institute at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Paul D. P. Pharoah,

  Affiliation Strangeways Research Laboratory, Cancer Research United Kingdom, Department of Oncology, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Honglin Song,

  Affiliation Strangeways Research Laboratory, Cancer Research United Kingdom, Department of Oncology, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Susanne Krüger Kjær,

  Affiliations Danish Cancer Society, Copenhagen, Denmark, Gynecologic Clinic, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Estrid Høgdall,

  Affiliation Danish Cancer Biobank, Copenhagen and Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Claus Høgdall,

  Affiliation Gynecologic Clinic, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Lene Lundvall,

  Affiliation Gynecologic Clinic, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Lotte Nedergaard,

  Affiliation Department of Pathology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Lambertus A. L. M. Kiemeney,

  Affiliation Department of Epidemiology, Biostatistics, and Health Technology Assessment, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

  ⨯
• Leon F. A. G. Massuger,

  Affiliation Department of Obstetrics and Gynaecology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

  ⨯
• Anne M. van Altena,

  Affiliation Department of Obstetrics and Gynaecology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

  ⨯
• Sita H. H. M. Vermeulen,

  Affiliation Department of Epidemiology, Biostatistics, and Health Technology Assessment, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

  ⨯
• Nhu D. Le,

  Affiliation Cancer Control Research, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

  ⨯
• Angela Brooks-Wilson,

  Affiliations Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada, Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, British Columbia, Canada

  ⨯
• Linda S. Cook,

  Affiliations Department of Population Health Research, Alberta Health Services-Cancer Care, Calgary, Alberta, Canada, Division of Epidemiology and Biostatistics, University of New Mexico, Albuquerque, New Mexico, United States of America

  ⨯
• Catherine M. Phelan,

  Affiliation Division of Cancer Prevention and Control, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America

  ⨯
• Julie M. Cunningham,

  Affiliation Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Celine M. Vachon,

  Affiliation Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Robert A. Vierkant,

  Affiliation Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Edwin S. Iversen,

  Affiliation Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Andrew Berchuck,

  Affiliation Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Ellen L. Goode,

  Affiliation Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Thomas A. Sellers,

  Affiliation Division of Cancer Prevention and Control, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America

  ⨯
•  [ ... ],
• Linda E. Kelemen

  * E-mail: LKelemen@post.harvard.edu

  Affiliations Department of Population Health Research, Alberta Health Services-Cancer Care, Calgary, Alberta, Canada, Departments of Oncology and Medical Genetics, University of Calgary, Calgary, Alberta, Canada

  ⨯
• [ view all ]
• [ view less ]